FinHarbor Introduces Neobank Platform Designed to Go Live in Under 30 Days

FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live

Hello IP Reshapes Content Marketing Through a Creator-Driven Distribution Model

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo

HYVE.Promo Launches as APAC’s Newest Print-on-Demand Platform for Corporate Gifting — Powered by AI and Built for Scale

AI Labs Introduces AI-Assisted Crypto Trading Platform Focused on Data Analysis and Automated Execution

CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

Core Concepts Physiotherapy Partners with Podiatry Quest to Deliver Enhanced Assessments for Patients with Plantar Fasciitis

BASIS Accelerates Platform Development Following $35M Capital Injection

FinHarbor Completes Core Deployment of Hybrid Neobank Platform for Asterium in Uzbekistan

AI Safety Asia Advances Crisis Diplomacy and Evidence-Based AI Governance at India AI Impact Summit 2026

CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China

Malaysian Content Creators Immerse Themselves in Jiaxing’s Spring Festival Festivities, Discovering the Depth and Warmth of a Jiangnan Chinese New Year

Dr. Don Hits Seven-Figure Milestones on Three Music Videos in Less than a Year

playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group

TCG.Zone Participates in a Historic Moment Surrounding the World’s Only PSA 10 ‘Pikachu Illustrator’